VEGFA and chorioretinitis: With regard to the pathophysiology described above, anti-vascular endothelial growth factor (anti-VEGF) agents have been identified as a revolutionary treatment plan for the management of chorioretinal diseases.2 They act by inhibiting the action of VEGF thus controlling the effects caused by NV.